North America Urinalysis Market Opportunity and Forecast 2021 to 2028 

The North America Urinalysis Market is expected to grow from US$ 1,432.01 million in 2021 to US$ 2,129.13 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2021 to 2028.

The North America Urinalysis Market is a dynamic landscape characterized by both established and emerging players. Competition is intensifying as companies prioritize strategies like new product introductions, geographical expansion, and technological advancements to gain a larger market share. The increasing demand for rapid, point-of-care (PoC), and portable testing solutions is a significant driver for new product launches in this sector. PoC testing offers the advantage of quick results outside traditional laboratory settings, enhancing efficiency. These cost-effective tests are valuable tools for diagnosing a wide array of diseases. Furthermore, the growing preference for PoC diagnostics is fueling innovation within the North America Urinalysis Market, with companies actively investing in research and development to create cutting-edge technologies.

North America Urinalysis Market Introduction:

The North America urinalysis market encompasses the United States, Canada, and Mexico, with the US currently holding the dominant share. This growth is primarily driven by a rising prevalence of chronic diseases, the strong presence of key industry participants, and extensive research and development activities undertaken by various research institutions and laboratories. Additionally, increasing public healthcare expenditure and growing awareness programs are expected to further stimulate market expansion.

The COVID-19 pandemic and the subsequent lockdowns imposed across North American countries led to a temporary decline in healthcare checkups, consequently impacting the volume of tests performed and the sales of urinalysis instruments, consumables, and reagents. However, as restrictions on movement have gradually eased, testing numbers are showing a recovery. Notably, research from the National Kidney Foundation indicates that individuals hospitalized with COVID-19 face a considerable risk of acute kidney injury (AKI), potentially leading to severe illness, the need for dialysis, and even death.

For COVID-19 survivors who experienced AKI or acute renal failure, urinalysis is recommended due to their heightened risk of developing chronic kidney disease compared to others. Even COVID-19 patients without AKI but with the presence of blood and/or protein in their urine require monitoring, as they are at a greater risk of developing chronic and end-stage kidney disease. The pandemic also influenced the regulatory environment, prompting authorities to expedite the approval processes for diagnostic products. Companies responded strategically by introducing rapid COVID-19 tests to sustain revenue streams and mitigate the pandemic's impact on their operations. For example, in August 2020, Sysmex America, Inc. partnered with Siemens Healthineers to broaden the distribution of the CLINITEK Novus automated urine chemistry analyzer platform. Looking ahead, with the progression of COVID-19 vaccination programs and a reduction in transmission rates, healthcare systems are expected to normalize, generating significant long-term demand for urinalysis products and services.

North America Urinalysis Market Strategic Insights

Strategic insights for the North America urinalysis market provide a data-centric analysis of the industry's landscape, encompassing current trends, key market players, and specific regional dynamics. These insights offer actionable recommendations designed to enable stakeholders to differentiate themselves from competitors by identifying underserved market segments or developing unique value propositions. By leveraging data analytics, these insights empower industry participants, including investors and manufacturers, to anticipate market shifts. Adopting a forward-looking perspective is crucial for stakeholders to proactively prepare for market changes and position themselves for sustained success within this evolving region. Ultimately, effective strategic insights equip readers with the knowledge necessary to make informed decisions that drive profitability and achieve their business objectives within the North American urinalysis market.

North America Urinalysis Market Segmentation

North America Urinalysis Market - By Product

• Consumables

• Instruments

North America Urinalysis Market - By Test Type

• Pregnancy and Fertility Tests

• Biochemical Urinalysis

• Sediment Urinalysis

North America Urinalysis Market - By Application

• Disease Screening

• Pregnancy and Fertility

North America Urinalysis Market - By End User

• Hospitals and Clinics

• Diagnostic Laboratories

• Home Care Settings

• Research Laboratories and Institutes

North America Urinalysis Market - By Country

• US

• Canada

• Mexico

North America Urinalysis Market - Company Profiles

• Abbott    

• ACON Laboratories, Inc.             

• ARKRAY, Inc.     

• Beckman Coulter, Inc.     

• Bio-Rad Laboratories Inc.            

• Cardinal Health Inc         

• F. Hoffmann-La Roche Ltd.          

• Quidel Corporation          

• Siemens Healthineers AG           

• Sysmex Corporation

Other Report:

North America Long Read Sequencing Market: https://sites.google.com/view/northamericalongreadsequencing/home 

North America Artificial Intelligence in Market: https://penzu.com/p/c83823c9bffd9c4e 

North America Multiple Sclerosis Therapeutics Market: https://business-news-insights.blogspot.com/2025/04/north-america-multiple-sclerosis.html 

North America Artificial Intelligence (AI) in Healthcare Market: https://sites.google.com/view/artificial-intelligence-na/home 

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Author’s Bio:

Suryakant Gadekar

Senior Market Research Expert at Business Market Insights